IQ-AI Limited (IQAI.L)
- Previous Close
1.5500 - Open
1.6000 - Bid 1.5000 x --
- Ask 1.6000 x --
- Day's Range
1.5000 - 1.7000 - 52 Week Range
1.2700 - 5.8000 - Volume
21,122 - Avg. Volume
853,626 - Market Cap (intraday)
3.547M - Beta (5Y Monthly) 2.94
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 6, 2011
- 1y Target Est
--
IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey, the United Kingdom, and the United States. Its products include IB Clinic, a toolkit of post-processing software plug-ins for integrating into existing medical image visualization applications; IB Rad Tech, a workflow engine that processes customized workflows; IB Neuro, which analyzes MR data sets and generates parametric perfusion maps quantifying changes in contrast over time; and IB Delta Suite that performs a various fundamental radiology operations, including image co-registration, subtraction, class map generation, and export. The company also offers IB DCE, which analyzes conventional T1 weighted images and generates an array of relevant perfusion and permeability parameters; IB Diffusion that analyzes MR diffusion-weighted images and generates apparent diffusion coefficient, extrapolated b-value, IVIM, and other parameter maps; and IB StoneChecker, a medical software tool to aid clinical decision making by providing information about a patient's kidney stone. In addition, it provides consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018. The company is based in Saint Helier, Jersey.
www.imagingbiometrics.com/iq-ai-ltd6
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: IQAI.L
Performance Overview: IQAI.L
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IQAI.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IQAI.L
Valuation Measures
Market Cap
3.55M
Enterprise Value
3.30M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.19
Price/Book (mrq)
8.53
Enterprise Value/Revenue
6.15
Enterprise Value/EBITDA
-9.15
Financial Highlights
Profitability and Income Statement
Profit Margin
-85.53%
Return on Assets (ttm)
-24.00%
Return on Equity (ttm)
-77.81%
Revenue (ttm)
562.93k
Net Income Avi to Common (ttm)
-481.49k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
90.21k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-177.51k
Company Insights: IQAI.L
IQAI.L does not have Company Insights